PDF. Explore the latest unit-wise weightage, detailed chapter topics, question paper design, and internal assessment details ...

The results of two phase 3 trials investigating Survodutide, a weight loss drug from Boehringer Ingelheim, suggest that the ...

An overburdened, underresourced, and gridlocked Congress has contributed to executive abuse, Supreme Court overreach, and ...

Harvest at Limoneira and real estate pipeline -- Anticipated $155 million combined cash proceeds over next 5 fiscal years; ...

Regeneron's EYLEA HD US sales surged 52% in Q1 2026, offsetting competitive pressures and patient switching within the EYLEA ...

This year’s Top 40 electrical design firms see a double-digit revenue boost amidst more demand concentration in the data ...

Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 4:00 PM EDTCompany ParticipantsAlexander Cumbo ...

North Topsail Beach has introduced two tax rates for next year’s budget as its board of aldermen awaits potential impacts ...

Gamehaus Holdings Inc. ("Gamehaus" or the "Company") (Nasdaq: GMHS), a technology-driven mobile game publisher, today announced ...

Background Pulmonary hypertension (PH) medical therapies are commonly used as a bridge to balloon pulmonary angioplasty (BPA) ...

Detailed price information for Acumen Pharmaceuticals Inc (ABOS-Q) from The Globe and Mail including charting and trades.

On track to complete enrollment for the Phase 3 PROACT 1 accelerated approval analysis of rilparencel in mid-2026; anticipate pivotal topline results in Q2 2027 Peer-reviewed results from the Phase 2 ...